The birmingham pediatric bone-anchored hearing aid program: a 15-year experience

Ann-Louise McDermott1, Jo Williams, Michael Kuo

  • 1Department of Otolaryngology, Birmingham Children's Hospital, Birmingham, UK. annlouisemcdermott@msn.com

Insights

The Birmingham Bone-Anchored Hearing Aid (BAHA) program successfully treated children, with 97% wearing their devices daily. Despite a 14% fixture failure rate, BAHA proved effective for selected pediatric patients.

Area of Science:

  • Otolaryngology
  • Pediatric Audiology
  • Biomedical Engineering

Background:

  • Bone-anchored hearing aids (BAHA) offer a solution for hearing loss in children.
  • The Birmingham BAHA program has been providing this treatment since 1992.

Purpose of the Study:

  • To evaluate complication rates and outcomes in pediatric patients receiving BAHA.
  • To assess the effectiveness and reliability of the BAHA program in children.

Main Methods:

  • Retrospective analysis of clinical records from 182 children (<16 years) treated between 1992 and 2007.
  • Evaluation of surgical procedures, healing times, implant failures, and adverse skin reactions.

Main Results:

  • A 14% fixture failure rate was observed, with multiple failures in 7 patients.
  • Adverse skin reactions occurred in 17% of patients, necessitating revision surgery in 8%.
  • Despite complications, 97% of children actively use their BAHA with ongoing audiological benefit.

Conclusions:

  • The Birmingham BAHA program serves a high proportion of syndromic children with complex medical needs.
  • BAHA is a reliable and effective treatment for carefully selected pediatric patients.
  • High daily usage rates indicate successful long-term outcomes and patient satisfaction.
Abstract

Related Concept Videos